OncoMatch/Clinical Trials/NCT06412510
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Is NCT06412510 recruiting? Yes, currently enrolling (May 2026). This Phase 1/2 trial studies non-drug interventions for ovarian cancer.
The purpose of this study is to see whether participants who are assigned to a multimodal prehabilitation intervention during chemotherapy are able to adhere with exercise and nutrition program to prepare for their cancer surgery.
Check if I qualifyExtracted eligibility criteria
Cancer type
Ovarian Cancer
Pancreatic Cancer
Disease stage
Required: Stage III, IV
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center · Cleveland, Ohio
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify